| 55 | 0 | 6 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 探讨中国老年人群中内脏肥胖指标对慢性肾脏病(CKD)的预测价值。方法 对上海市闵行区接受国家基本公共卫生服务(老年人健康管理服务项目)中62 774名老年人采用Spearman相关分析和多因素Logistic回归分析内脏肥胖指标与CKD之间的关系，采用受试者工作特征(ROC)曲线评价不同内脏肥胖指标对CKD的预测价值。结果 男性和女性CKD的患病率分别是18.41%和21.89%。内脏肥胖指标与CKD患病存在关联，并且在调整了混杂因素后这种关联仍然存在，内脏肥胖指标评分增加，老年人患CKD的风险增加。ROC曲线分析显示，男性和女性中内脏肥胖指标[内脏脂肪指数(VAI)、新VAI(NVAI)、中国VAI(CVAI)、腰围(WC)、脂质蓄积指数(LAP)、体形指数(ABSI)、体圆度指数(BRI)、胰岛素抵抗代谢评分(METS-VF)]与CKD的AUC均>0.5(P<0.001),其中NVAI与CKD的AUC最大，男性AUC为0.620(95%CI:0.617～0.628)和女性AUC为0.611(95%CI:0.604～0.618)。结论 内脏肥胖指标对CKD具有一定预测价值，其中NVAI的预测价值最高。
Abstract：1 Ene-Iordache B,Perico N,Bikbov B,et al.Chronic kidney disease and cardiovascular risk in six regions of the world(ISN-KDDC):a cross-sectional study[J].Lancet Glob Health,2016;4(5):e307-19.
2 王善志，朱永俊，唐文庄，等.中国成人及老年人群慢性肾脏病患病率Meta分析[J].中国老年学杂志，2017;37(21):5384-8.
3 张鹏，高鹰，杨洪喜，等.中国长寿地区老年人血尿酸水平与慢性肾脏病发病风险研究[J].中国全科医学，2023;26(31):3884-9,3907.
4 Kim B,Kim GM,Oh S.Use of the visceral adiposity index as an indicator of chronic kidney disease in older adults:comparison with body mass index[J].Clin Med,2022;11(21):6297.
5 Hall JE,do Carmo JM,da Silva AA,et al.Obesity,kidney dysfunction and hypertension:mechanistic links[J].Nat Rev Nephrol,2019;15(6):367-85.
6 Chang AR,Grams ME,Ballew SH,et al.Adiposity and risk of decline in glomerular filtration rate:meta-analysis of individual participant data in a global consortium[J].BMJ,2019;364:k5301.
7 Yu P,Meng X,Kan R,et al.Association between metabolic scores for visceral fat and chronic kidney disease:a cross-sectional study[J].Front Endocrinol(Lausanne),2022;13:1052736.
8 Jin J,Woo H,Jang Y,et al.Novel asian-specific visceral adiposity indices are associated with chronic kidney disease in Korean adults[J].Diabetes Metab J,2023;47(3):426-36.
9 Sun Y,Yan Y,Liao Y,et al.The new visceral adiposity index outperforms traditional obesity indices as a predictor of subclinical renal damage in Chinese individuals:a cross-sectional study[J].BMC Endocr Disord,2023;23(1):78.
10 高翔，梅长林.《慢性肾脏病早期筛查、诊断及防治指南(2022年版)》解读[J].中国实用内科杂志，2022;42(9):735-9.
11 Levey AS,Stevens LA,Schmid CH,et al.A new equation to estimate glomerular filtration rate[J].Ann Intern Med,2009;150(9):604-12.
12 中国高血压防治指南2018年修订版[J].心脑血管病防治，2019;19(1):1-44.
13 Amato MC,Giordano C,Galia M,et al.Visceral adiposity index:a reliable indicator of visceral fat function associated with cardiometabolic risk[J].Diabetes Care,2010;33(4):920-2.
14 Oh SK,Cho AR,Kwon YJ,et al.Derivation and validation of a new visceral adiposity index for predicting visceral obesity and cardiometabolic risk in a Korean population[J].PLoS One,2018;13(9):e0203787.
15 Xia MF,Chen Y,Lin HD,et al.A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese[J].Sci Rep,2016;6:38214.
16 Ou YL,Lee MY,Lin IT,et al.Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus[J].Ren Fail,2021;43:1250-8.
17 Kahn HS.The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk:a population-based comparison[J].BMC Cardiovasc Disord,2005;5:26.
18 Thomas DM,Bredlau C,Bosy-Westphal A,et al.Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model[J].Obesity(Silver Spring),2013;21(11):2264-71.
19 Krakauer NY,Krakauer JC,A new body shape index predicts mortality hazard independently of body mass index[J].PLoS One,2012;7:e39504.
20 Bello-Chavolla OY,Antonio-Villa NE,Vargas-Vázquez A,et al.Metabolic score for visceral fat(METSVF),a novel estimator of intra-abdominal fat content and cardio-metabolic health[J].Clin Nutr,2020;39(5):1613-21.
21 Bello-Chavolla OY,Almeda-Valdes P,Gomez-Velasco D,et al.METS-IR,a novel score to evaluate insulin sensitivity,is predictive of visceral adiposity and incident type 2 diabetes[J].Eur J Endocrinol,2018;178(5):533-44.
22 刘纪实，陈志恒，李维，等.26655例体检人群中肥胖指数与慢性肾脏病联系的横断面调查(英文)[J].中南大学学报(医学版),2016;41(5):445-54.
23 Kang SH,Cho KH,Park JW,et al.Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population:analysis using multi-frequency bioimpedance[J].Kidney Blood Pressure Res,2015;40(3):223-30.
24 Kataoka H,Mochizuki T,Iwadoh K,et al.Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease[J].PLoS One,2020;15(11):e0241626.
25 Bragina A,Osadchiy KK,Rodionova JN,et al.Pararenal fat and renal dysfunction in patients without significant cardiovascular disease[J].Am J Nephrol,2022;53(5):416-22.
26 Hall JE,do Carmo JM,da Silva AA,et al.Obesity,kidney dysfunction and hypertension:mechanistic links[J].Nat Rev Nephrol,2019;15(6):367-85.
27 Olivero A,Basso L,Barabino E,et al.The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma[J].Minerva Urol Nephrol,2021;73(6):789-95.
28 Son DH,Ha HS,Lee HS,et al.Association of the new visceral adiposity index with coronary artery calcification and arterial stiffness in Korean population[J].Nutr Metab Cardiovasc Dis,2021;31(6):1774-81.
基本信息:
中图分类号:R692
引用信息:
[1]俞艳,李俊,蒋炳鑫,等.内脏肥胖指标对老年人慢性肾脏病的预测价值[J].中国老年学杂志,2026,46(06):980-985.